TNC and infection: Plasma levels of tenascin-C, together with AST, also provide an effective model to discriminate HCV cirrhotic patients with active infection from healthy controls and patients with undetectable levels of HCV RNA post HCV treatment regimen, highlighting tenascin-C as a potential indicator of ongoing hepatic injury and inflammation in these patients (369).